About Us  
 We are developing potentially best in class therapies for patients living with severe autoimmune diseases. Our lead antibody, claseprubart (DNTH103), is purposefully engineered with extended half-life, improved potency, and high selectivity for only the active... 
                  Dianthus Therapeutics
                  
                  
                  
                  
                    
                    8 days ago